BioNTech (BNTX) Stock: Buy, Sell, or Hold?
BNTX - BioNTech SE American Depositary Share
$89.67
-1.62 (-1.77%)
▼
5d:
-0.59%
30d:
-8.93%
90d:
+0.38%
BUY
HIGH Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 03, 2026
10d
Get Alerted When BNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BNTX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: BNTX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: BNTX is currently trading at $89.67, which is considered oversold relative to its 30-day fair value range of $91.93 to $99.29.
Technical Outlook: Technically, BNTX is in a uptrend. The price is currently testing key support at $87.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BNTX scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $117.39 (+30.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BNTX is in a uptrend. The price is currently testing key support at $87.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BNTX scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $117.39 (+30.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$91.93 -
$99.29
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (85/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.9% below Wall St target ($117.39)
- BULLISH: Bottoming setup score 85/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$91.93 -
$99.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$87.36
Resistance Level
$98.60
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.63
Wall Street Target
$117.39
(+30.9%)
Revenue Growth (YoY)
-59.5%
Earnings Growth (YoY)
-43.2%
Profit Margin
-63.6%
Share & Embed Analysis
Last updated: October 22, 2026 11:37 PM ET
Data refreshes hourly during market hours. Next update: 12:37 AM
Data refreshes hourly during market hours. Next update: 12:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 68 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 71 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 60 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 68 BUY |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 60 BUY |
